The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2016
DOI: 10.1016/j.jstrokecerebrovasdis.2016.07.024
|View full text |Cite
|
Sign up to set email alerts
|

Multiple Cerebral Infarctions in a Patient with Adenomyosis on Hormone Replacement Therapy: A Case Report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
30
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(30 citation statements)
references
References 7 publications
0
30
0
Order By: Relevance
“…Some patients with adenomyosis develop multiple cerebral infarctions (CIs) [ 3 5 ] (Table 1 ). Almost all patients are middle-aged, with severe anemia and elevated serum carbohydrate antigen 125 (CA125).…”
Section: Introductionmentioning
confidence: 99%
“…Some patients with adenomyosis develop multiple cerebral infarctions (CIs) [ 3 5 ] (Table 1 ). Almost all patients are middle-aged, with severe anemia and elevated serum carbohydrate antigen 125 (CA125).…”
Section: Introductionmentioning
confidence: 99%
“…Regarding acute cerebral infarction with adenomyosis, we consulted cases and found 13 patients in the cases [2][3][4][5][6][7][8]. The median age of the 13 patients was 45.4 years.…”
Section: Discussionmentioning
confidence: 99%
“…The pathway can cause systemic thrombin and even can cause DIC in extreme cases. Blood stagnation caused by intramural hemorrhage in adenomyosis during menstruation may activate the tissue factor (TF) coagulation pathway [3]. Although TF plays a key role in the initiation of coagulation, TF also involves in the pathogenesis of adenomyosis and may involve in angiogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…[Ref] Age (y.o) CA125 (U/mL) D-dimer (μg/mL) Secondary prevention Recurrence 1 [ 9 ] 45 159 1.1 Antiplatelet, GnRH agonist (−) 2 [ 9 ] 44 Not mentioned FDP 5.9 μg/mL Warfarin, GnRH agonist (−) 3 [ 9 ] 55 42.6 0.57 (normal) Aspirin, GnRH agonist (−) 4 [ 8 ] a 42 1750 6.0 Antiplatelet (6 m). GnRH agonist (6 m) (+) 5 [ 9 ] a 42 907 4.1 Warfarin, GnRH agonist (−) 6 [ 11 ] 59 334.8 7.0 Discontinuation of hormone replacement therapy (−) 7 b 42 395 1.4 Warfarin (−) 8 b 50 143 3.7 Rivaroxaban (−) a Case Nos. 4 and 5 are the same patient b Case Nos.…”
Section: Discussionmentioning
confidence: 99%
“…Long-term hormone replacement therapy may cause hypercoagulability in patients with adenomyosis, and discontinuation of this therapy in one reported case (Case No. 6, Table 1 ) did not lead to recurrence [ 11 ]. Overall, further studies are needed to clarify the mechanisms of development of cerebral infarction in patients with adenomyosis or other mucin-producing benign.…”
Section: Discussionmentioning
confidence: 99%